Concepedia

Chunxiao Wang

CW

39

Publications

1.4K

Citations

21

H-Index

2007

Active since

Affiliations

Eli Lilly (United States)(Current)

Second Affiliated Hospital of Fujian Medical University

Fujian Medical University

Massachusetts General Hospital

The University of Texas MD Anderson Cancer Center

Chunxiao Wang is an author at Eli Lilly (United States) specializing in medicine, cancer research, and pathology.

ORCID

Top concepts

Publications per year

2007–2024

39

Publications

39

Induction of ferroptosis by ATF3 elevation alleviates cisplatin resistance in gastric cancer by restraining Nrf2/Keap1/xCT signaling

Dazhi Fu, Chunxiao Wang, Lei Yu et al. · Cellular & Molecular Biology Letters · 2021 · 263 citations · Full text

Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia

Anthony R. Mato, Jennifer A. Woyach, Jennifer R. Brown et al. · New England Journal of Medicine · 2023 · 190 citations · Full text

A Nuclear Transport Inhibitor That Modulates the Unfolded Protein Response and Provides In Vivo Protection Against Lethal Dengue virus Infection

Johanna E. Fraser, Satoru Watanabe, Chunxiao Wang et al. · The Journal of Infectious Diseases · 2014 · 102 citations · Full text

Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumab

Andrew X. Zhu, Richard S. Finn, Yoon‐Koo Kang et al. · British Journal of Cancer · 2021 · 63 citations · Full text

Effect of ramucirumab on ALBI grade in patients with advanced HCC: Results from REACH and REACH-2

Masatoshi Kudo, Peter R. Galle, Giovanni Brandi et al. · JHEP Reports · 2020 · 53 citations · Full text

Rows per page

1–5 of 39